MOR - MorphoSys AG

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-56,172.121-69,826.469-60,382.77614,900.768
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,244.2593,345.9483,763.8132,784.842
Adjustments To Net Income23,659.927-5,157.119-4,959.483-67,782.794
Changes In Accounts Receivables-6,610.6251,362.347-1,154.5973,635.172
Changes In Liabilities4,276.05526,205.2130,451.0925,586.929
Changes In Inventories----
Changes In Other Operating Activities-2,173.0094,941.228-14,333.755-3,308.766
Total Cash Flow From Operating Activities-33,269.514-38,445.855-46,615.708-23,513.849
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-1,820.749-1,317.058-2,502.286-1,386.639
Investments-174,961.64645,823.513-79,885.871111,734.747
Other Cash flows from Investing Activities136.124257.7522,008.3251,466.156
Total Cash Flows From Investing Activities-177,262.40232,932.502-80,786.03686,268.898
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings1,020.8498,189.345-6.7071,330.758
Other Cash Flows from Financing Activities-15,172.631-15.525-2,780.471-3.433
Total Cash Flows From Financing Activities179,462.0868,173.82110,402.731-4,065.606
Effect Of Exchange Rate Changes-59.463-59.463-59.4630.069
Change In Cash and Cash Equivalents-31,129.2932,660.467-16,999.01358,689.512